NDC codes

FDA NDC Directory
Product NDC (as listed)0781-3431Labeler and product segments. Claims need a package NDC.
Product NDC at billing width00781-3431Add the package segment from the table below.

Product information

Brand name (proprietary)
Linezolid
Generic name (nonproprietary)
linezolid
Active ingredients
Linezolid — 200 mg/100mL
Dosage form
Injection, Solution
Route
Intravenous
Labeler
Sandoz IncNDC labeler code 0781
Product type
Prescription drug
Marketing category
ANDA — Abbreviated New Drug Application (generic)Application ANDA 200904
Marketing start
Listing expires
Other FDA classes
Oxazolidinones (Chemical structure)
Identifiers
Product ID 0781-3431_1cfcbbf5-11a6-44a4-a36f-5f77931baec1SPL ID 1cfcbbf5-11a6-44a4-a36f-5f77931baec1SPL set ID a287cdf4-47a8-459f-8890-86181af5e836RxCUI 1662278, 1662285UNII ISQ9I6J12JUPC 0307813431466
Pharmacologic class
Oxazolidinone Antibacterial

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

Product label

Current FDA label (SPL), effective .

Indications (excerpt from the label)

Linezolid injection is an oxazolidinone-class antibacterial indicated in adults and children for the treatment of the following infections caused by susceptible Gram-positive bacteria: Nosocomial pneumonia ( 1.1 ); Community-acquired pneumonia ( 1.2 ); Complicated skin and skin structure infections, including diabetic foot infections, without concomitant osteomyelitis ( 1.3 ); Vancomycin-resistant Enterococcus faecium infections. ( 1.5 ) Limitations of Use ( 1.6 ): • Linezolid is not indicated for the treatment of Gram-negative infections. • The safety and efficacy of Linezolid formulations given for longer than 28 days have not been evaluated in controlled clinical trials. To reduce the dev…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 0781-3431

What is NDC 0781-3431?
0781-3431 is the product NDC for Linezolid, Linezolid 200 mg/100mL injection, solution, listed with the FDA by Sandoz Inc.
What drug is associated with this NDC?
Linezolid.
What is the active ingredient?
Linezolid.
Who is the labeler?
Sandoz Inc, NDC labeler code 0781. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Linezolid?
32 other product NDCs are listed under this name. See all Linezolid NDCs.
Is there a related HCPCS / J-code?
Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Linezolid NDCs
ProductStrengthForm · routeLabelerProduct NDCPackage NDCs (11-digit)
LinezolidLinezolid 600 mg/300mLInjection, SolutionIntravenousCaplin Steriles Limited65145-18165145-0181-10
LinezolidLinezolid 600 mg/1Tablet, Film coatedOralCoupler LLC67046-157667046-1576-03
LinezolidLinezolid 600 mg/1Tablet, CoatedOralMacleods Pharmaceuticals Limited33342-35233342-0352-0633342-0352-1133342-0352-31+1 more
LinezolidLinezolid 600 mg/1Tablet, Film coatedOralREMEDYREPACK INC.70518-403470518-4034-0070518-4034-01
LinezolidLinezolid 600 mg/300mLInjection, SolutionIntravenousPiramal Critical Care Inc66794-21966794-0219-43
LinezolidLinezolid 600 mg/300mLInjectionIntravenousPiramal Critical Care Inc.66794-23666794-0236-43
LinezolidLinezolid 600 mg/1TabletOralRising Pharma Holdings, Inc.64980-56164980-0561-0264980-0561-03
LinezolidLinezolid 600 mg/1TabletOralSportpharm LLC85766-07585766-0075-2085766-0075-30
LinezolidLinezolid 100 mg/5mLGranule, For suspensionOralAmerican Health Packaging60687-75460687-0754-05
LinezolidLinezolid 600 mg/300mLInjection, SolutionIntravenousHikma Pharmaceuticals USA Inc.0143-953400143-9534-10

All 33 Linezolid NDCs

Other NDCs under ANDA 200904

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 200904
ProductStrengthForm · routeLabelerProduct NDC
LinezolidLinezolid 600 mg/300mLInjection, SolutionIntravenousSandoz Inc0781-3433

Free account

Log in to keep searching

You’ve used your 3 free searches. Med-Code is free: log in or create a free profile to keep looking up NDCs, J-codes and drugs.

Create a free profileLog in